Matamoros J, Rubio-Casado S, Fernandez-Albarral J, Martinez-Lopez M, Salobrar-Garcia E, Marco E
Antioxidants (Basel). 2025; 14(1).
PMID: 39857338
PMC: 11761561.
DOI: 10.3390/antiox14010004.
Namdari M, McDonnell F
Vision Res. 2024; 226:108522.
PMID: 39581065
PMC: 11640964.
DOI: 10.1016/j.visres.2024.108522.
Yang T, Kang E, Lin P, Yu B, Wang J, Chen V
Int J Mol Sci. 2024; 25(16).
PMID: 39201313
PMC: 11354650.
DOI: 10.3390/ijms25168626.
Langbol M, Saruhanian A, Saruhanian S, Tiedemann D, Baskaran T, Vohra R
Cell Mol Neurobiol. 2024; 44(1):59.
PMID: 39150567
PMC: 11329415.
DOI: 10.1007/s10571-024-01492-3.
Ullah Z, Tao Y, Huang J
Int J Mol Sci. 2024; 25(15).
PMID: 39125762
PMC: 11311784.
DOI: 10.3390/ijms25158193.
TLR4 deficiency does not alter glaucomatous progression in a mouse model of chronic glaucoma.
Zhang C, Simon M, Harder J, Lim H, Montgomery C, Wang Q
bioRxiv. 2024; .
PMID: 38895321
PMC: 11185798.
DOI: 10.1101/2024.06.07.597951.
Neuroprotective effects of resveratrol on retinal ganglion cells in glaucoma in rodents: A narrative review.
Golmohammadi M, Meibodi S, Al-Hawary S, Gupta J, Sapaev I, Najm M
Animal Model Exp Med. 2024; 7(3):195-207.
PMID: 38808561
PMC: 11228121.
DOI: 10.1002/ame2.12438.
Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review).
Qin P, Sun Y, Li L
Int J Mol Med. 2024; 53(5).
PMID: 38577947
PMC: 10999227.
DOI: 10.3892/ijmm.2024.5371.
Stress, Allostatic Load, and Neuroinflammation: Implications for Racial and Socioeconomic Health Disparities in Glaucoma.
McDermott C, Salowe R, Rosa I, OBrien J
Int J Mol Sci. 2024; 25(3.
PMID: 38338933
PMC: 10855412.
DOI: 10.3390/ijms25031653.
Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage.
Fernandez-Albarral J, Ramirez A, de Hoz R, Matamoros J, Salobrar-Garcia E, Elvira-Hurtado L
Front Cell Neurosci. 2024; 18:1354569.
PMID: 38333055
PMC: 10850296.
DOI: 10.3389/fncel.2024.1354569.
Distinct Metabolic Profiles of Ocular Hypertensives in Response to Hypoxia.
Langbol M, Rovelt J, Saruhanian A, Saruhanian S, Tiedemann D, Baskaran T
Int J Mol Sci. 2024; 25(1).
PMID: 38203366
PMC: 10779258.
DOI: 10.3390/ijms25010195.
Therapeutic Potential of Antioxidants and Hybrid TEMPOL Derivatives in Ocular Neurodegenerative Diseases: A Glimpse into the Future.
Amankwa C, Kodati B, Donkor N, Acharya S
Biomedicines. 2023; 11(11).
PMID: 38001960
PMC: 10669210.
DOI: 10.3390/biomedicines11112959.
Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment.
Buonfiglio F, Pfeiffer N, Gericke A
Pharmaceuticals (Basel). 2023; 16(9).
PMID: 37765001
PMC: 10535738.
DOI: 10.3390/ph16091193.
Metabolic syndrome as an independent risk factor for glaucoma: a nationally representative study.
Lee J, Kwon Y, Kim S, Joung B
Diabetol Metab Syndr. 2023; 15(1):177.
PMID: 37620923
PMC: 10464157.
DOI: 10.1186/s13098-023-01151-5.
The Role of Mitophagy in Glaucomatous Neurodegeneration.
Stavropoulos D, Grewal M, Petriti B, Chau K, Hammond C, Garway-Heath D
Cells. 2023; 12(15).
PMID: 37566048
PMC: 10417839.
DOI: 10.3390/cells12151969.
Exosome-based crosstalk in glaucoma pathogenesis: a focus on oxidative stress and neuroinflammation.
Wang L, Wei X
Front Immunol. 2023; 14:1202704.
PMID: 37529047
PMC: 10388248.
DOI: 10.3389/fimmu.2023.1202704.
Modulation of Mitochondrial Metabolic Parameters and Antioxidant Enzymes in Healthy and Glaucomatous Trabecular Meshwork Cells with Hybrid Small Molecule SA-2.
Amankwa C, Young O, DebNath B, Gondi S, Rangan R, Ellis D
Int J Mol Sci. 2023; 24(14).
PMID: 37511316
PMC: 10380487.
DOI: 10.3390/ijms241411557.
Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson's Disease.
Ravenhill S, Evans A, Crewther S
Antioxidants (Basel). 2023; 12(5).
PMID: 37237983
PMC: 10215182.
DOI: 10.3390/antiox12051117.
Mitochondrial dysfunction in glaucomatous degeneration.
Zhang Z, Xie Z, Chen S, Zhang X
Int J Ophthalmol. 2023; 16(5):811-823.
PMID: 37206187
PMC: 10172101.
DOI: 10.18240/ijo.2023.05.20.
Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal Diseases.
Mohtashami Z, Singh M, Neto F, Salimiaghdam N, Hasanpour H, Kenney M
Antioxidants (Basel). 2023; 12(2).
PMID: 36830076
PMC: 9952431.
DOI: 10.3390/antiox12020518.